The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.
Open Access
- 1 September 1983
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 46 (9) , 854-855
- https://doi.org/10.1136/jnnp.46.9.854
Abstract
Sixteen women with multiple sclerosis who complained of nocturia completed a double-blind cross-over trial of Desmopressin (DDAVP) and placebo. Nocturia was reduced from a mean of 2.55 voids to 2.01 with placebo and to 1.28 with Desmopressin (p less than 0.01, for the difference between placebo and Desmopressin). Side effects were minor, and equally distributed between treatment and placebo.Keywords
This publication has 2 references indexed in Scilit:
- DDAVP for Adult Enuresis-a Preliminary ReportBritish Journal of Urology, 1982
- The Use of Desmopressin (DDAVP) in Nocturna Urinary Frequency in the FemaleBritish Journal of Urology, 1982